Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeDrugs

      Drugs

      Axovant Sciences Ltd. Shares Have Dropped Over 50% Today, Here’s Why.
      Drugs

      Axovant Sciences Ltd. Shares Have Dropped Over 50% Today, Here’s Why.

      January 8, 2018
      This is Why Spectrum Pharmaceuticals Stock Soared in October
      Health Services

      This is Why Spectrum Pharmaceuticals Stock Soared in October

      November 8, 2017
      Current Wall Street Outlooks on Impax Laboratories, Inc.
      Drugs

      Current Wall Street Outlooks on Impax Laboratories, Inc.

      October 30, 2017
      3D Signatures Announces Successful Clinical Trial Completion in New Lymphoma Drug
      Drugs

      3D Signatures Announces Successful Clinical Trial Completion in New Lymphoma Drug

      October 24, 2017
      3D Signatures, Inc. Closing Above PSAR
      Drugs

      3D Signatures, Inc. Closing Above PSAR

      October 12, 2017
      VBI Vaccines, Inc.: What Can We Learn From Indicators and Metrics?
      Drugs

      VBI Vaccines, Inc.: What Can We Learn From Indicators and Metrics?

      October 3, 2017
      An Analysis of pSivida Corp.
      Drugs

      An Analysis of pSivida Corp.

      October 2, 2017
      mCig, Inc. Begins Operations in California
      Cannabis

      mCig, Inc. Begins Operations in California

      October 2, 2017

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2025